Company Search:
Advanced Search
Sponsored Links
Nanorepro AG Company Snapshot
Nanorepro AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nanorepro AG with three other miscellaneous service companies in Europe: Active Biotech AB of Sweden (2017 sales of 20.20 million Swedish Kronor [US$2.39 million] ), Oxford Biodynamics PLC of the United Kingdom (£1.18 million [US$1.66 million] of which 100% was Pharmaceutical), and Heidelberg Pharma Ag (1.90 million Euro [US$2.33 million] ).

Sales Analysis. During the year ended December of 2017, sales at Nanorepro AG were 1.66 million Euro (US$2.04 million). This is an increase of 7.8% versus 2016, when the company's sales were 1.54 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nanorepro AG
  Stock Performance Chart for Nanorepro AG
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.41
(Figures in Euro)
1 Week -1.4%   13 Weeks 5.2%  
4 Weeks -8.8%   52 Weeks -1.7%  
Nanorepro AG Key Data:
  Ticker: NN6 Country: Germany
  Exchanges: FRA Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 1,659,281
(Year Ending Jan 2018).
Employees: 14
  Currency: Euro Market Cap: 9,613,010
  Fiscal Yr Ends: December Shares Outstanding: 6,842,000
  Share Type: Stammaktie Closely Held Shares: 355,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.